Preoperative Serum TMAO Level is a New Prognostic Marker for Colorectal Cancer

201761 citationsJournal Article

Authors

Pretreatment serum TMAO level is identified as a new independent prognostic biomarker in patients with colorectal cancer.

Good health and well-being

Published in: Biomarkers in Medicine

Volume 11, Issue 5, pp. 443-447

Field-Weighted Citation Impact: 1.24